Canadian Sciences Speakers Network

Réseau Canadien de Panélistes Scientifiques

Lisa Porter: CSSN Speaker

Lisa Porter

Windsor, Ontario

Position: Distinguished Professor

Organization: University of Windsor

Dr. Lisa Porter is passionate about the value that research excellence brings to the health and care of the community that we serve. She leads a team of scientists and students to find new and better ways to rapidly detect and treat cancer. She has a deep appreciation for the importance of multi-disciplinary, collaborative research conducted with patients and the community to ensure rapid and effective translation of results and knowledge which fosters innovation & impact in the healthcare system.

Areas of Expertise:

+ Cancer
+ Research communications
+ Health

Language(s):

+ English

About Me

English proficiency: Read, Write, Speak

Willing to Mentor: Yes

Title: Dr.

Pronouns: She/Her/Hers

Gender: Female

Recent Publications

Title Year
Atypical cell cycle regulation over neural stem cell expansion2026
Patient perspective of Hesitancies and strategies to increase cancer clinical trial participation2026
Clinical Significance of Tumor Grade in Triple-Negative Breast Cancer: A Retrospective Cohort Analysis2025
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative2025
Boron in My Mind: A Comprehensive Review of the Evolution of the Diverse Syntheses of 4‐Borono‐ l ‐Phenylalanine, the Leading Agent for Boron Neutron Capture Therapy2025
Long-Term Survival in Human Epidermal Growth Factor Receptor 2-Positive Bone-Only Metastatic Breast Cancer: Trastuzumab, Denosumab, and Potential Synergistic Effects2024
Regulation of biological processes by ubiquitin ligases: a focus on the Pagano Lab’s contribution2024
Atypical cell cycle regulation promotes mammary stem cell expansion during mammary development and tumourigenesis2024
High‐impact practices in cancer education and research: Undergraduate students’ perceptions of skills and career development2024
Evaluating and optimizing Acid-pH and Direct Lysis RNA extraction for SARS-CoV-2 RNA detection in whole saliva2024
Presentation and Outcome of Patients with Multiple Myeloma (MM), Single Centre Experience from Windsor Essex Regional Cancer Centre2024
E‐learning and research experience exchange in the online setting of student peer mentor network during COVID‐19 pandemic and beyond: A laboratory case study2023
Actionable wastewater surveillance: application to a university residence hall during the transition between Delta and Omicron resurgences of COVID-192023
Tuberin levels during cellular differentiation in brain development2022
Frequently used antiemetic agent dexamethasone enhances the metastatic behaviour of select breast cancer cells2022
Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments2022
Dissecting the roles of the Tuberin protein in the subcellular localization of the G2/M Cyclin, Cyclin B12022
Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticles2022
Fitted filtration efficiency and breathability of 2-ply cotton masks: Identification of cotton consumer categories acceptable for home-made cloth mask construction2022
A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer2022
Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells2022
Beyond Protein Synthesis; The Multifaceted Roles of Tuberin in Cell Cycle Regulation2022
A revised synthesis of 6-alkoxy-2-aminopurines with late-stage convergence allowing for increased molecular complexity2022
Barriers to translational research in Windsor Ontario: a survey of clinical care providers and health researchers2021
Averting an Outbreak of SARS-CoV-2 in a University Residence Hall through Wastewater Surveillance2021